Samabriva Competitors and Similar CompaniesClear all
Gyre Therapeutics's competitors and similar companies include Idogen.
 Gyre Therapeutics Gyre Therapeutics (formerly known as Catalyst Biosciences) is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases. | ||
Founding Date | Founding Date 2003 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Lund, SE HQ |
Employees | Employees 3462% increase | Employees 10 |
Valuation ($) | Valuation ($) 19.4 m | Valuation ($) 1.2 m |
Financial | ||
Revenue (est.) | Revenue (est.) $116.6m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $5.4m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $111.2m (FY, 2025) | Gross profit kr272k (FY, 2022) |
Net income | Net income $9.9m (FY, 2025) | Net income (kr47.8m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Idogen
HQ
Lund, SE
Employees
10
Idogen is a biotechnology company that develops tolerogenic cell therapies.
View company